Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. Outdoors
  5. Photography
  6. Wearables
  7. Legacy Archives

Turn skiing into a video game: Oakley partners with Garmin for next-gen HUD goggles

Add as a preferred source on Google

Just in time for winter, Oakley has unveiled a new and improved version of its popular Airwave ski goggles. This time around, the company teamed up with Garmin to bring additional functionality to the goggs — namely, compatibility with the Garmin VIRB Elite action camera.

As far as we can tell from the company’s press release, the goggles themselves aren’t much different than they were in previous generations. They still contain the same heads-up display technology from Recon Insturments, and aside from the new action cam compatibility and slightly improved graphics, the specs and features are the same.

oakley garmin
Image used with permission by copyright holder

Don’t let that fool you, though; the Airwave 1.5 goggles are still pretty stacked, even without a major hardware update. If you’re unfamiliar, these goggs can track your speed and location via GPS, measure your elevation with barometric pressure data, provide jump/airtime analytics with the help of accelerometers, track your friends on the slopes, control music playback, and even display incoming calls and text messages — all right in front of your eyes.

Recommended Videos

Related: Recon announces new and improved Snow2 HUD goggles

But just when we thought Oakley couldn’t pack Airwave 1.5 with any more tech, the company went ahead and did it anyway. With this new Garmin integration, users will be able to connect the goggles wirelessly to the VIRB Elite action camera (sold separately) and sync video recordings with data and analytics recorded by the Airwave’s onboard sensors. This way, the epic footage of you hucking yourself off that last kicker will be supplemented with data like speed, distance, and airtime stats.

Oakley Airwave 1.5 goggles and the Garmin VIRB Elite action camera are available at Oakley.com, Oakley Stores and select retail destinations.

Drew Prindle
Former Senior Editor, Features
Drew Prindle is an award-winning writer, editor, and storyteller who currently serves as Senior Features Editor for Digital…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more